Lonhala™ Magnair™ (glycopyrrolate) – New drug approval
December 5, 2017 – Sunovion announced the FDA approval of Lonhala Magnair (glycopyrrolate), for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Top